ReviewDrug design, development and therapy2025

Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development.

Zhanyi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.